Malignant Melanoma Archive - Seite 2 von 18 - IOZK

Interferon-α2b enhances survival and modulates transcriptional profiles and the immune response in melanoma patients treated with dendritic cell vaccines

2020-01-31/in Dendritic Cells, Malignant Melanoma /von 2020-01-31 / Biomed. Pharmacother. 2020 May;125:109966

Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial

2020-01-24/in Dendritic Cells, International Publications, Malignant Melanoma /von 2020-01-24 / Cancer Immunol. Immunother. 2020 Mar;69(3):477-488

Genomic, proteomic, and immunologic associations with a durable complete remission of measurable metastatic melanoma induced by a patient-specific dendritic cell vaccine

2019-11-15/in Dendritic Cells, International Publications, Malignant Melanoma /von 2019-11-15 / Hum Vaccin Immunother 2020 04;16(4):742-755

Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment

2019-10-11/in Dendritic Cells, International Publications, Malignant Melanoma /von 2019-10-11 / Biomedicines 2019 Oct;7(4)

Dendritic Cell Vaccination in Metastatic Melanoma Turns „Non-T Cell Inflamed“ Into „T-Cell Inflamed“ Tumors

2019-10-09/in Dendritic Cells, International Publications, Malignant Melanoma /von 2019-10-09 / Front Immunol 2019;10:2353

Stress-Induced, p53-Mediated Tumor Growth Inhibition of Melanoma by Modulated Electrohyperthermia in Mouse Models without Major Immunogenic Effects

2019-08-17/in Hyperthermia, International Publications, Malignant Melanoma /von 2019-08-17 / Int J Mol Sci 2019 Aug;20(16)

A phase II open labeled, randomized study of poly-ICLC matured dendritic cells for NY-ESO-1 and Mean-A peptide vaccination compared to Montanide, in melanoma patients in complete clinical remission.

2019-06-03/in Dendritic Cells, International Publications, Malignant Melanoma /von 2019-06-03 / J Clin Oncol 37, 2019 (suppl; abstr 9538)

Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma

2019-05-31/in Dendritic Cells, International Publications, Malignant Melanoma /von 2019-05-31 / Melanoma Manag 2019 May;6(2):MMT20

Dendritic cell vaccination in metastatic uveal melanoma as compassionate treatment: Immunological and clinical responses.

2019-05-31/in Dendritic Cells, International Publications, Malignant Melanoma /von 2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e21024)

Clinical efficacy of vaccination with the autologous tumor lysate particle loaded dendritic cell (TLPLDC) vaccine in metastatic melanoma.

2019-05-31/in Dendritic Cells, International Publications, Malignant Melanoma /von 2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e21025)